Seth Loring Harrison insider trades

Open-market stock purchases and sales by Seth Loring Harrison, Unknown at Stoke Therapeutics, Inc, from SEC Form 4 filings since May 4, 2010.

Track record: 75% of 4 scored buys are up 5% or more since purchase, averaging +74%.

Recent trades

DateStockTradeValue
Jul 16, 2026STOK Stoke Therapeutics, IncBought (not open market)—
Jul 16, 2026STOK Stoke Therapeutics, IncBought (not open market)—
Jul 16, 2026STOK Stoke Therapeutics, IncBought (not open market)—
Jul 16, 2026STOK Stoke Therapeutics, IncBought (not open market)—
Jul 16, 2026STOK Stoke Therapeutics, IncBought (not open market)—
Jul 16, 2026STOK Stoke Therapeutics, IncBought (not open market)—
Jul 16, 2026STOK Stoke Therapeutics, IncBought (not open market)—
Jul 16, 2026STOK Stoke Therapeutics, IncBought (not open market)—
Jun 3, 2026STOK Stoke Therapeutics, IncBought (not open market)—
Dec 9, 2025AKRO Akero Therapeutics, IncSold (not open market)$328K
Dec 9, 2025AKRO Akero Therapeutics, IncSold (not open market)$519K
Dec 9, 2025AKRO Akero Therapeutics, IncSold (not open market)—
Dec 9, 2025AKRO Akero Therapeutics, IncSold (not open market)—
Dec 9, 2025AKRO Akero Therapeutics, IncSold (not open market)—
Dec 9, 2025AKRO Akero Therapeutics, IncSold (not open market)$122K

Companies traded

  • STOK Stoke Therapeutics, Inc: 2 buys, last Jul 16, 2026
  • AKRO Akero Therapeutics, Inc: 2 buys, 22 sales, last Dec 9, 2025
  • HTWR HeartWare International, Inc: 29 sales, last Aug 23, 2016
  • TKAI Tokai Pharmaceuticals Inc: 1 buy, last Jun 15, 2016

Get free alerts when Seth Loring Harrison files a new trade →